2005
DOI: 10.1001/archderm.141.7.865
|View full text |Cite
|
Sign up to set email alerts
|

Sarcoidosis Associated With Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
67
0
4

Year Published

2007
2007
2024
2024

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(71 citation statements)
references
References 17 publications
0
67
0
4
Order By: Relevance
“…• Polyethylene glycol (PEG)-containing product, seems to induce more frequent adverse reactions and a large number of side-effect cases related to combination therapy with ribavirin have been reported [65][66][67][68][69].…”
Section: General Characteristicsmentioning
confidence: 99%
“…• Polyethylene glycol (PEG)-containing product, seems to induce more frequent adverse reactions and a large number of side-effect cases related to combination therapy with ribavirin have been reported [65][66][67][68][69].…”
Section: General Characteristicsmentioning
confidence: 99%
“…Its onset may vary from 2 weeks to 3 years after beginning of treatment. Men and women are equally affected [42,43], and the mean age of patients was approximately 50 years [39]. The majority (roughly two-thirds) of cases of IIS arise during the first 6 months of IFN therapy, but clinical manifestations may also appear after discontinuation of the antiviral treatment [38].…”
Section: Interferon-induced Sarcoidosismentioning
confidence: 99%
“…Even treatment-naive HCV-infected patients develop sarcoidosis with mainly pulmonary involvement and also with cutaneous involvement. Sarcoidosis may initially manifest or be reactivated during or shortly after treatment with antiviral therapy in patients with chronic HCV infection [134,135].…”
Section: Sarcoidosismentioning
confidence: 99%